What is Proteos?
Proteos is a distinguished contract service organization renowned for its expertise in producing high-quality recombinant proteins and antibodies. Leveraging advanced mammalian, insect, and bacterial cell expression systems, the company offers comprehensive purification and analytics services. Based in Kalamazoo, Michigan, Proteos is committed to ethical and environmentally responsible operations, ensuring customer satisfaction through tailored solutions delivered by an experienced scientific team. Their focus on specialized protein and antibody production positions them as a key player in the biotechnology services market.
How much funding has Proteos raised?
Proteos has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Proteos?
With the recent strategic investment, Proteos is well-positioned to accelerate its growth trajectory and enhance its service offerings. This capital infusion is expected to fuel further development of its production capabilities and potentially expand its market reach. The company's late-stage funding context indicates a strategic focus on scaling operations, solidifying its market leadership, and exploring new avenues for innovation in recombinant protein and antibody services. Proteos is likely to prioritize expanding its client base and strengthening its research and development initiatives.
See full Proteos company page
